Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00B52SFT06
| Stock Name / Fund | iShares MSCI USA UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | CU1(GBX) LSE |
| ETF Ticker | SXR4(EUR) F |
| ETF Ticker | CSUS.LS(USD) CXE |
| ETF Ticker | CSUS.MI(EUR) CXE |
| ETF Ticker | CSUSz(USD) CXE |
| ETF Ticker | SXR4.DE(EUR) CXE |
| ETF Ticker | CSUS(EUR) Euronext Amsterdam |
| ETF Ticker | CU1.L(GBP) LSE |
Holdings detail for RPRX
| Stock Name | Royalty Pharma Plc |
| Ticker | RPRX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | GB00BMVP7Y09 |
| LEI | 549300FGFN7VOK8BZR03 |
Show aggregate RPRX holdings
News associated with RPRX
- Royalty Pharma Expects At Least Mid-teens Average Annual Total Shareholder Return Over 2025-2030.
- (RTTNews) - Royalty Pharma plc (RPRX) Thursday said it will host an Investor Day today, where senior executives will provide updates on the company's strategies aimed at driving shareholder value creation. - 2025-09-11 08:35:29
- Maryland State Retirement & Pension System Trims Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
- Maryland State Retirement & Pension System lessened its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 18.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,291 shares of the biopharmaceutical company’s stock after selling 4,133 shares during the quarter. […] - 2025-08-15 05:22:58
- PNC Financial Services Group Inc. Acquires 859 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
- PNC Financial Services Group Inc. boosted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 7.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,665 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-08-15 04:48:59
- Blair William & Co. IL Invests $212,000 in Royalty Pharma PLC (NASDAQ:RPRX)
- Blair William & Co. IL bought a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,801 shares of the biopharmaceutical company’s stock, valued at approximately $212,000. A number of other hedge […] - 2025-08-13 07:56:48
- Deutsche Bank AG Sells 1,775,038 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
- Deutsche Bank AG lessened its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 55.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,414,926 shares of the biopharmaceutical company’s stock after selling 1,775,038 shares during the period. Deutsche Bank AG’s holdings in Royalty Pharma were worth $44,047,000 as of its most recent […] - 2025-08-13 05:54:50
- Charles Schwab Investment Management Inc. Has $97.20 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
- Charles Schwab Investment Management Inc. cut its holdings in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 0.3% in the 1st quarter, Holdings Channel.com reports. The firm owned 3,122,531 shares of the biopharmaceutical company’s stock after selling 9,097 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Royalty Pharma were worth $97,204,000 as […] - 2025-08-13 05:10:46
- Royalty Pharma (NASDAQ:RPRX) Raised to Buy at Wall Street Zen
- Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other equities research analysts also recently weighed in on the company. Morgan Stanley boosted their target price on Royalty Pharma from $51.00 […] - 2025-08-11 03:50:55
- Allianz Asset Management GmbH Has $6.03 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX)
- Allianz Asset Management GmbH reduced its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 64.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 193,591 shares of the biopharmaceutical company’s stock after selling 356,968 shares during the period. Allianz […] - 2025-07-28 07:00:47
- Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX)
- Edgestream Partners L.P. acquired a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 21,158 shares of the biopharmaceutical company’s stock, valued at approximately $659,000. Other hedge funds and other institutional investors also […] - 2025-07-20 05:24:59
- Cerity Partners LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
- Cerity Partners LLC raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 786.3% during the 1st quarter, Holdings Channel reports. The fund owned 153,846 shares of the biopharmaceutical company’s stock after purchasing an additional 136,487 shares during the period. Cerity Partners LLC’s holdings in Royalty Pharma were worth $4,789,000 as […] - 2025-07-17 05:00:57
- Xponance Inc. Acquires 1,437 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
- Xponance Inc. raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 3.7% in the first quarter, HoldingsChannel.com reports. The firm owned 40,133 shares of the biopharmaceutical company’s stock after buying an additional 1,437 shares during the period. Xponance Inc.’s holdings in Royalty Pharma were worth $1,249,000 as of its most […] - 2025-07-16 05:48:56
- M&T Bank Corp Buys 5,500 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
- M&T Bank Corp raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 23.4% in the 1st quarter, Holdings Channel reports. The firm owned 28,967 shares of the biopharmaceutical company’s stock after acquiring an additional 5,500 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $902,000 at […] - 2025-07-15 06:23:30
- Teacher Retirement System of Texas Cuts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX)
- Teacher Retirement System of Texas cut its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 10.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 103,364 shares of the biopharmaceutical company’s stock after selling 12,028 shares during the […] - 2025-07-09 05:33:01
- Allspring Global Investments Holdings LLC Boosts Stake in Royalty Pharma PLC (NASDAQ:RPRX)
- Allspring Global Investments Holdings LLC boosted its position in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 561,724 shares of the biopharmaceutical company’s stock after acquiring an additional 21,729 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Royalty […] - 2025-07-03 06:09:03
- 11,210 Shares in Royalty Pharma PLC (NASDAQ:RPRX) Acquired by Kentucky Retirement Systems Insurance Trust Fund
- Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) in the first quarter, HoldingsChannel reports. The firm acquired 11,210 shares of the biopharmaceutical company’s stock, valued at approximately $349,000. Other hedge funds also recently bought and sold shares of the company. Louisbourg Investments Inc. […] - 2025-06-26 05:42:57
- After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
- The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 17:24:56
- Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
- Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 05:20:57
- After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
- The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 17:24:56
- Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
- Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 05:24:51
- Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
- Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 05:46:49
- Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
- Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 04:50:51
- Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
- Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 04:52:44
- Analysts Predict 10% Gains Ahead For The Holdings of EUSA
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:59:43
- Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
- Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 02:14:45
- Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
- Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 04:50:58
- Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
- Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 05:01:02
- American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
- American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 04:26:56
- Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
- JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 04:44:55
- Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
- Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 05:29:08
- Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
- Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 02:14:52
iShares MSCI USA UCITS ETF USD (Acc) RPRX holdings
| Date | Number of RPRX Shares Held | Base Market Value of RPRX Shares | Local Market Value of RPRX Shares | Change in RPRX Shares Held | Change in RPRX Base Value | Current Price per RPRX Share Held | Previous Price per RPRX Share Held |
|---|
| 2025-09-29 (Monday) | 18,369 | USD 647,507 | USD 647,507 | | | | |
| 2025-09-26 (Friday) | 18,297 | USD 641,127 | USD 641,127 | 0 | USD 2,562 | USD 35.04 | USD 34.9 |
| 2025-09-25 (Thursday) | 18,297 | USD 638,565 | USD 638,565 | 0 | USD -15,919 | USD 34.9 | USD 35.77 |
| 2025-09-24 (Wednesday) | 18,297 | USD 654,484 | USD 654,484 | 792 | USD 29,030 | USD 35.77 | USD 35.73 |
| 2025-09-18 (Thursday) | 17,505 | USD 625,454 | USD 625,454 | 0 | USD 1,576 | USD 35.73 | USD 35.64 |
| 2025-09-17 (Wednesday) | 17,505 | USD 623,878 | USD 623,878 | 0 | USD 3,851 | USD 35.64 | USD 35.42 |
| 2025-09-16 (Tuesday) | 17,505 | USD 620,027 | USD 620,027 | 0 | USD 4,726 | USD 35.42 | USD 35.15 |
| 2025-09-15 (Monday) | 17,505 | USD 615,301 | USD 615,301 | | | | |
| 2025-09-12 (Friday) | 17,433 | USD 633,864 | USD 633,864 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of RPRX by Blackrock for IE00B52SFT06
Show aggregate share trades of RPRX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-09-24 | BUY | 792 | | | 35.770* | | 31.91 |
| 2025-07-17 | SELL | -72 | | | 35.470* | | 31.69 Profit of 2,282 on sale |
| 2025-07-15 | SELL | -72 | | | 36.510* | | 31.63 Profit of 2,278 on sale |
| 2025-07-10 | BUY | 144 | | | 36.120* | | 31.55 |
| 2025-07-02 | BUY | 144 | | | 36.190* | | 31.36 |
| 2025-06-27 | BUY | 216 | | | 35.870* | | 31.30 |
| 2025-05-28 | SELL | -72 | | | 32.630* | | 30.80 Profit of 2,218 on sale |
| 2025-04-14 | BUY | 128 | | | 32.290* | | 30.14 |
| 2025-04-11 | BUY | 128 | | | 31.950* | | 30.12 |
| 2025-04-04 | SELL | -2,794 | | | 31.110* | | 30.05 Profit of 83,969 on sale |
| 2025-03-19 | SELL | -126 | | | 33.410* | | 29.71 Profit of 3,743 on sale |
| 2025-03-17 | SELL | -128 | | | 33.020* | | 29.61 Profit of 3,790 on sale |
| 2025-03-12 | BUY | 256 | | | 32.850* | | 29.47 |
| 2025-03-11 | BUY | 254 | | | 32.460* | | 29.43 |
| 2025-03-10 | BUY | 762 | | | 32.750* | | 29.38 |
| 2025-03-07 | BUY | 252 | | | 33.010* | | 29.32 |
| 2025-03-06 | BUY | 126 | | | 33.280* | | 29.26 |
| 2025-03-05 | BUY | 126 | | | 33.770* | | 29.19 |
| 2025-03-04 | BUY | 381 | | | 33.320* | | 29.13 |
| 2025-03-03 | BUY | 252 | | | 33.860* | | 29.05 |
| 2025-02-27 | BUY | 645 | | | 33.370* | | 28.90 |
| 2025-02-26 | BUY | 256 | | | 33.380* | | 28.83 |
| 2025-02-18 | BUY | 384 | | | 32.850* | | 28.32 |
| 2025-02-05 | BUY | 126 | | | 31.450* | | 27.57 |
| 2025-01-31 | BUY | 126 | | | 31.580* | | 27.29 |
| 2024-12-30 | BUY | 251 | | | 25.320* | | 26.63 |
| 2024-11-20 | BUY | 504 | | | 26.220* | | 26.91 |
| 2024-11-18 | BUY | 645 | | | 25.800* | | 27.03 |
| 2024-11-12 | BUY | 127 | | | 26.000* | | 27.10 |
| 2024-11-07 | BUY | 630 | | | 26.520* | | 27.21 |
| 2024-10-24 | BUY | 127 | | | 27.280* | | 27.49 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of RPRX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 877,435 | 0 | 1,269,348 | 69.1% |
| 2025-09-18 | 854,156 | 255 | 1,225,709 | 69.7% |
| 2025-09-17 | 890,428 | 0 | 1,130,889 | 78.7% |
| 2025-09-16 | 849,691 | 0 | 1,371,042 | 62.0% |
| 2025-09-15 | 1,310,051 | 875 | 1,800,476 | 72.8% |
| 2025-09-12 | 1,066,120 | 800 | 1,339,292 | 79.6% |
| 2025-09-11 | 1,220,120 | 283 | 1,532,656 | 79.6% |
| 2025-09-10 | 1,195,119 | 790 | 1,440,333 | 83.0% |
| 2025-09-09 | 1,259,853 | 924 | 1,521,804 | 82.8% |
| 2025-09-08 | 1,967,280 | 1,094 | 3,312,547 | 59.4% |
| 2025-09-05 | 2,792,926 | 0 | 4,789,487 | 58.3% |
| 2025-09-04 | 649,497 | 0 | 1,396,642 | 46.5% |
| 2025-09-03 | 741,511 | 0 | 3,964,244 | 18.7% |
| 2025-09-02 | 1,164,461 | 621 | 1,836,122 | 63.4% |
| 2025-08-29 | 568,848 | 644 | 1,099,441 | 51.7% |
| 2025-08-28 | 343,443 | 1,229 | 665,672 | 51.6% |
| 2025-08-27 | 718,529 | 15 | 1,134,797 | 63.3% |
| 2025-08-26 | 376,806 | 3,158 | 782,116 | 48.2% |
| 2025-08-25 | 523,360 | 0 | 1,666,116 | 31.4% |
| 2025-08-22 | 416,975 | 1,403 | 983,556 | 42.4% |
| 2025-08-21 | 515,906 | 1 | 789,605 | 65.3% |
| 2025-08-20 | 668,934 | 557 | 1,359,619 | 49.2% |
| 2025-08-19 | 282,363 | 1,211 | 801,139 | 35.2% |
| 2025-08-18 | 470,777 | 713 | 735,143 | 64.0% |
| 2025-08-15 | 370,886 | 0 | 849,955 | 43.6% |
| 2025-08-14 | 437,271 | 0 | 1,270,825 | 34.4% |
| 2025-08-13 | 450,930 | 0 | 2,187,219 | 20.6% |
| 2025-08-12 | 378,708 | 321 | 1,366,736 | 27.7% |
| 2025-08-11 | 566,603 | 322 | 1,321,771 | 42.9% |
| 2025-08-08 | 732,304 | 1,141 | 1,058,552 | 69.2% |
| 2025-08-07 | 637,779 | 141 | 1,478,119 | 43.1% |
| 2025-08-06 | 968,026 | 95 | 1,335,306 | 72.5% |
| 2025-08-05 | 817,147 | 97 | 1,153,956 | 70.8% |
| 2025-08-04 | 562,562 | 677 | 830,964 | 67.7% |
| 2025-08-01 | 356,771 | 847 | 641,246 | 55.6% |
| 2025-07-31 | 550,713 | 210 | 657,912 | 83.7% |
| 2025-07-30 | 529,655 | 432 | 816,351 | 64.9% |
| 2025-07-29 | 600,859 | 25 | 752,372 | 79.9% |
| 2025-07-28 | 682,728 | 1,073 | 824,975 | 82.8% |
| 2025-07-25 | 351,993 | 50 | 514,201 | 68.5% |
| 2025-07-24 | 396,410 | 57 | 557,229 | 71.1% |
| 2025-07-23 | 289,217 | 2,996 | 787,220 | 36.7% |
| 2025-07-22 | 460,421 | 0 | 666,171 | 69.1% |
| 2025-07-21 | 489,845 | 1,682 | 693,054 | 70.7% |
| 2025-07-18 | 355,376 | 0 | 587,434 | 60.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.